Search results
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 2 hours agoGlobal vaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 8 hours agoThe vaccine is based on protein technology, differentiating it from Pfizer's and ... is appealing to...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 3 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 11 hours agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 18 hours agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 5 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA Roundup: June 7, 2024
KOIN News 6 Portland· 5 hours agoToday, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 13 hours agoModerna also recently gained FDA approval for its second product, the RSV shot. In older adults, the...
Moderna's RSV Vaccine Approved by FDA
Medscape· 5 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join ...